The human pregnancy-specific glycoproteins (PSGs) are a family of proteins that are synthesized in large amounts by placental trophoblasts and released into the maternal circulation during pregnancy.  The PSGs form a subgroup of the carcinoembryonic antigen (CEA) gene family, which belongs to the immunoglobulin superfamily (IgSF).  Members of the CEA family consist of a single N domain, with structural similarity to the Ig variable (IgV) domains, followed by a variable number of Ig constant-like 1 (IgC1) and/or 2 (IgC2) domains.  Most PSGs have an arg-gly-asp (RGD) motif, which has been shown to function as an adhesion recognition signal for several integrins, in the N-terminal domain.  PSG9 (Pregnancy-specific beta-1-glycoprotein 9) is a secreted glycoprotein of the CEA family. Human PSG9 contains 1 V-type Ig-like domain (IgV) and 3 C2-type (IgC2) domains with multiple sites for glycosylation. PSG9 is is a product of the syncytiotrophoblast.  The human placenta is a multihormonal endocrine organ that produces hormones, enzymes, and other molecules that support fetal survival and development. PSG9 is thought to inhibit platelet-fibrinogen interactions. Reduced serum concentrations of PSGs may be associated with fetal growth restrictions, while up-regulation of PSG9 has been observed in colorectal cancers. 

The human pregnancy-specific glycoproteins (PSGs) are a family of proteins that are synthesized in large amounts by placental trophoblasts and released into the maternal circulation during pregnancy.  The PSGs form a subgroup of the carcinoembryonic antigen (CEA) gene family, which belongs to the immunoglobulin superfamily (IgSF).  Members of the CEA family consist of a single N domain, with structural similarity to the Ig variable (IgV) domains, followed by a variable number of Ig constant-like 1 (IgC1) and/or 2 (IgC2) domains.  Most PSGs have an arg-gly-asp (RGD) motif, which has been shown to function as an adhesion recognition signal for several integrins, in the N-terminal domain.  PSG9 (Pregnancy-specific beta-1-glycoprotein 9) is a secreted glycoprotein of the CEA family. Human PSG9 contains 1 V-type Ig-like domain (IgV) and 3 C2-type (IgC2) domains with multiple sites for glycosylation. PSG9 is is a product of the syncytiotrophoblast.  The human placenta is a multihormonal endocrine organ that produces hormones, enzymes, and other molecules that support fetal survival and development. PSG9 is thought to inhibit platelet-fibrinogen interactions. Reduced serum concentrations of PSGs may be associated with fetal growth restrictions, while up-regulation of PSG9 has been observed in colorectal cancers. 

  

Product Details

 

Gene Symbol: PSG9; PSG-89; PSBG9; PSBG-9; PS-beta-G-9; PS34; PSG11; PSGII; PSBG11

 

NCBI Gene ID: 5678

 

Uniprot Entry: Q00887

 

Construct Details: Full length human PSG9 gene is subcloned into the Lentiviral expression vector pLTC with an upstream CMV promoter and with or without a selection marker, which can be used for both transient and stable expression in mammalian cells.  It can be co-transfected with the LentiPAK DNA mix (SKU# LP-001) into HEK293 cells to produce high titer lentiviral particles. Multiple choices of a stable antibiotic selection marker are available.

 

Vector Type: pLTC or pLTC-IRES-Marker (lentiviral expression vector containing a heterologous CMV promoter, see the vector map above)

 

Formulation: Supplied with 10 μg of endotoxin-free plasmid DNA at 200 ng/μl in sterile TE buffer (pH8.0)

 

Gene Insert Size: 1281 (bp)

 

Gene Insert Sequence:  

ATGGGGCCCCTCCCAGCCCCTTCCTGCACACAGCGCATCACCTGGAAGGGGCTCCTGCTCACAGCATCAC

TTTTAAACTTCTGGAACCCGCCCACCACTGCCGAAGTCACGATTGAAGCCCAGCCACCCAAAGTTTCTGA

GGGGAAGGATGTTCTTCTACTTGTCCACAATTTGCCCCAGAATCTTCCTGGCTACTTCTGGTACAAAGGG

GAAATGACGGACCTCTACCATTACATTATATCGTATATAGTTGATGGTAAAATAATTATATATGGGCCTG

CATACAGTGGAAGAGAAACAGTATATTCCAACGCATCCCTGCTGATCCAGAATGTCACCCGGAAGGATGC

AGGAACCTACACCTTACACATCATAAAGCGAGGTGATGAGACTAGAGAAGAAATTCGACATTTCACCTTC

ACCTTATACTTGGAGACTCCCAAGCCCTACATCTCCAGCAGCAACTTAAACCCCAGGGAGGCCATGGAGG

CTGTGCGCTTAATCTGTGATCCTGAGACTCTGGACGCAAGCTACCTATGGTGGATGAATGGTCAGAGCCT

CCCTGTGACTCACAGGTTGCAGCTGTCCAAAACCAACAGGACCCTCTATCTATTTGGTGTCACAAAGTAT

ATTGCAGGACCCTATGAATGTGAAATACGGAACCCAGTGAGTGCCAGTCGCAGTGACCCAGTCACCCTGA

ATCTCCTCCCGAAGCTGCCCATCCCCTACATCACCATCAACAACTTAAACCCCAGGGAGAATAAGGATGT

CTTAGCCTTCACCTGTGAACCTAAGAGTGAGAACTACACCTACATTTGGTGGCTAAACGGTCAGAGCCTC

CCCGTCAGTCCCGGGGTAAAGCGACCCATTGAAAACAGGATACTCATTCTACCCAGTGTCACGAGAAATG

AAACAGGACCCTATCAATGTGAAATACGGGACCGATATGGTGGCCTCCGCAGTAACCCAGTCATCCTAAA

TGTCCTCTATGGTCCAGACCTCCCCAGAATTTACCCTTCATTCACCTATTACCGTTCAGGAGAAAACCTC

GACTTGTCCTGCTTCACGGAATCTAACCCACCGGCAGAGTATTTTTGGACAATTAATGGGAAGTTTCAGC

AATCAGGACAAAAGCTCTTTATCCCCCAAATTACTAGAAATCATAGCGGGCTCTATGCTTGCTCTGTTCA

TAACTCAGCCACTGGCAAGGAAATCTCCAAATCCATGACAGTCAAAGTCTCTGGTCCCTGCCATGGAGAC

CTGACAGAGTCTCAGTCATGA

 

 

Primers: Gene insert coding sequence can be confirmed by following primers:

(a) forward (or 5'-end) primer: 5’-CAAATGGGCGGTAGGCGTG-3’;

(b) reverse (or 3'-end) primer: 5’-CCAGGTTTCCGGGCCCTCAC-3’

 

 

Note: The sequence may vary due to the naturally occurring variants or mutations, such as single nucleotide polymorphism, or the artifact during PCR amplification.  High fidelity PCR systems should always be used. 

 

 

 

 

 

FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC USE IN HUMAN.

Restriction: This product is not transferable or re-sellable.  Customer obtain no right to transfer, assign, or sublicense its use rights, or to transfer, resell, package, or otherwise distribute the product, or to use the product for the benefit of any third party or for any commercial purpose.  Customer may only use the product in compliance with applicable local, state and federal laws, regulations and rules.  Customer may not directly or indirectly use the product or allow the transfer, transmission, export or re-export of all or any part of the product in violation of any export control law or regulation of the united states or any other relevant jurisdiction.  Your use of this product constitutes acceptance of the terms of this limited use agreement.  Please refer to our “terms & conditions” for details.  If you are not willing to accept the limitation of this agreement, G&P Biosciences will accept return of the product for a full/partial refund.

 

Storage

 

The product is shipped at 4°C. Upon receipt, centrifuge the product briefly before opening the vial. It is recommended to store small aliquots at the temperature below –20°C for long-term storage and the product is stable for 6 months. 

 

 

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

 

 

 

 

FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC USE IN HUMAN.

 

References

 

 

Additional supporting documents, including PDS, COA and MSDS are available upon request.

 

 

 

FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC USE IN HUMAN.

Restriction: This product is not transferable or re-sellable.  Customer obtain no right to transfer, assign, or sublicense its use rights, or to transfer, resell, package, or otherwise distribute the product, or to use the product for the benefit of any third party or for any commercial purpose.  Customer may only use the product in compliance with applicable local, state and federal laws, regulations and rules.  Customer may not directly or indirectly use the product or allow the transfer, transmission, export or re-export of all or any part of the product in violation of any export control law or regulation of the united states or any other relevant jurisdiction.  Your use of this product constitutes acceptance of the terms of this limited use agreement.  Please refer to our “terms & conditions” for details.  If you are not willing to accept the limitation of this agreement, G&P Biosciences will accept return of the product for a full/partial refund.